Oz Wiltshire.

ozwiltshire.bsky.social

18 October 2026 12:02

Trastuzumab deruxtecan (Enhertu): Listed on the PBS for patients with metastatic (Stage IV) HER2-positive breast cancer, reducing the cost from about $425,000 per course down to a maximum of $30 per script (or $7.30 with a concession card).

Oz Wiltshire.

ozwiltshire.bsky.social

18 October 2026 12:02

Triptorelin (3.75mg): Added to the PBS starting 1 October 2026, dropping the cost from up to $1,370 per script down to no more than $25 per script (or less with a concession card). This medication treats breast cancer, endometriosis, and uterine fibroids, more 👇

Oz Wiltshire.

ozwiltshire.bsky.social

18 October 2026 12:02

💪 youtube.com/shorts/qwDGC...

Oz Wiltshire.

ozwiltshire.bsky.social

18 October 2026 12:02

Horses and their pet cats 🥰 youtube.com/shorts/YrfSA...

Tori

toti66.bsky.social

17 October 2026 15:22

link.ms.now/click/479724...